Safety concerns involving transdermal patches and magnetic resonance imaging (MRI)

Hospital Pharmacy

Volumn 45, Issue 10, 2010, Pages 771-778

  Hong, Irene ^a   Gabay, Michael ^a   Lodolce, Amy ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

burns; magnetic resonance imaging; transdermal

Indexed keywords

CLONIDINE; DICLOFENAC; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; FENTANYL; GLYCERYL TRINITRATE; LIDOCAINE; METHYLPHENIDATE; NICOTINE; NICOTINE PATCH; OXYBUTYNIN; RIVASTIGMINE; SALONPAS; SCOPOLAMINE; SELEGILINE; SYNERA; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BURN; DRUG SAFETY; HEALTH CARE PERSONNEL; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSDERMAL PATCH;

EID: 77957768697     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4510-771     Document Type: Article

References (34)

1. Pfister WR, Hsieh DST. Permeation enhancers compatible with transdermal drug delivery systems part 1: selection and formulation considerations. Med Device Technol. 1990;1(6): 48-55.
2. Wilkosz MF, Bogner RH. Transdermal drug delivery. US Pharmacist. 2003;28(4).
3. Karch AM. Don't get burnt by the MRI. AJN. 2004; 104(8):31
4. Accessed June 23 2009 Institute for Safe Medication Practices Web site. http://www.ismp.org/Newsletters/acutecare/articles/20040408.asp. Accessed June 23, 2009
5. Transdermal medication patches and MRI procedures. http://www.mrisafety. com/safety-article.asp?subject=56. Accessed June 24, 2009.
6. Kuehn BM. FDA warning: remove drug patches before MRI to prevent burns to skin. JAMA. 2009;301(13):1328.
7. Alora [package insert]. Corona, CA: Watson Pharma; 2005.
8. Estraderm [package insert]. East Hanover, NJ: Novartis Pharmaceuticals; 2007.
9. Vivelle-dot [package insert]. Miami FL: Noven Pharmaceuticals Inc; 2004.
10. Climara [package insert]. Wayne, NJ: Bayer Healthcare Pharmaceuticals; 2007.
11. Menostar [package insert]. Wayne, NJ: Bayer Healthcare Pharmaceuticals; 2006.
12. Climara Pro [package insert]. Wayne, NJ: Bayer Health-care Pharmaceuticals; 2009.
13. Ortho-Evra [package insert]. Manati Puerto Rico: Jansson-Ortho LLC; 2001.
14. CombiPatch [package insert]. East Hanover, NH: Novartis Pharmaceuticals; 2006.
15. Androderm [package insert]. Corona, CA: Watson Phar-ma; 1999
16. Habitrol product information. http://www.habitrol.com/product.html. Accessed June 25, 2009.
17. Drugs.com. NicoDerm CQ. http://www.drugs.com/pdr/nicoderm-cq.html. Accessed June 25, 2009.
18. Nitro-Dur [package insert]. Kenilworth NJ: Key Phar-maceuticals Inc; 2004.
19. β Healthcare Series [Internet database]. Green-wood Village, CO: Thomson Reuters (Healthcare) Inc. Updated periodically.
20. Flector [package insert]. Piscataway NJ: King Pharma-ceuticals LLC; 2008.
21. Duragesic [package insert]. Titusville NJ: Ortho-McNeil-Janssen Pharmaceuticals Inc; 2008.
22. IONSYS [package insert]. Raritan NJ: Ortho-McNeil Inc.; 2006.
23. Lidoderm [package insert]. Chadds Ford, PA: Endo Pharmaceuticals; 2008.
24. Synera [package insert]. Salt Lake City, UT: Zars Pharma; 2008.
25. Catapres [package insert]. Ridgefield, CT: Boehringer In-gelheim Pharmaceuticals; 1998.
26. Transderm Scop [package insert]. Mountain View, CA: ALZA Corporation; 2006.
27. Oxytrol [package insert]. Corona, CA: Watson Pharma;2006.
28. Exelon [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2007.
29. Emsam [package insert]. Princeton, NJ: Bristol-Myers Squibb; 2008.
30. Daytrana [package insert]. Wayne PA: Shire US Inc; 2008.
31. Hulisz DT. Are topical patches safe during MRI or CT scans? http://www.medscape.com/viewarticle/572561. Accessed June 22, 2009.
32. Characteristics of transdermal patches. Pharmacist's Lett/Prescriber's Lett. 2008;24:240711.
33. US Food and Drug Administration. Public health advisory: risk of burns during MRI scans from transdermal drug patches with metallic backings. June 25, 2009. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsand Providers/ DrugSafetyInformationforHealthcareProfessionals/PublicHealthAdvisories/ ucm111313.htm.
34. Hitsamitsu Pharmaceuticals. SalonPas drug facts. http://www.newsalonpas. com/index.php?pg=drug-facts. Accessed January 5, 2010.